Am |
N-heterocyclic amine |
ATM |
ataxia telangiectasia mutated protein |
ATR |
ataxia telangiectasia and Rad3 related protein |
BAX |
BCL2-associated X protein |
cDPCP |
cis-diamminepyridinechloroplatinum(II) |
CHK1 |
checkpoint kinase 1 |
CHK2 |
checkpoint kinase 2 |
CSCs |
cancer stem cells |
CTP |
cytidine triphosphate |
CTR1 |
copper transporter 1 |
dCTP |
2′-deoxycytidine triphosphate |
dG |
2′-deoxyguanosine |
DNA |
deoxyribonucleic acid |
DNA pol η |
DNA polymerase η |
EMA |
European Medicines Agency |
ER |
endoplasmic reticulum |
FDA |
US Food and Drug Administration |
G2 phase |
gap 2 (between DNA synthesis and mitosis) phase |
H2AX |
H2A histone family, member X |
HMLER |
tumorigenic human mammary epithelial cell line |
HMGB1 |
high mobility group box protein 1 |
NER |
nucleotide excision repair |
NMR |
nuclear magnetic resonance |
OCT1/2 |
organic cation transporter 1/2 |
R,R-DACH |
R,R-1,2-diaminocyclohexane |
RNA pol II |
RNA polymerase II |